Valuation
- Market cap
- 263,648,000
- Revenue TTM
- $0
- Net income TTM
- $5,940,643
- PE ratio
- 0.00
- Forward PE
- —
- Profit margin
- 0.00%
- Debt to equity
- 0.00
Trading
- Volume
- 7,400
- Avg volume
- 28,446
- Day's range
- $10.85 – $10.87
- Shares out
- 24,277,000
- Stochastic %K
- 71%
- Beta
- 0.00
- Analysts
- Strong Buy
- Price target
- —
Company profile
Drugs Made In America Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combinations with one or more businesses. Drugs Made In America Acquisition Corp. was incorporated in 2024 and is based in New York, New York.
- Industry
- Shell Companies
- Sector
- Financial Services
- Phone
- 646 726 7074
- Address
- 420 Lexington Avenue, Suite 1402, New York, United States
Latest news
No headlines yet.
